These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 13708244)

  • 1. A preliminary report--resistance and cross-resistance of Escherichia coli mutants to radiomimetic agents.
    GREENBERG J; MANDELL JD; WOODY PL
    Cancer Chemother Rep; 1961 Apr; 11():51-6. PubMed ID: 13708244
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance and cross-resistance of Escherichia coli mutants to antitumour agent mitomycin C.
    GREENBERG J; MANDELL JD; WOODY PL
    J Gen Microbiol; 1961 Nov; 26():509-20. PubMed ID: 13901477
    [No Abstract]   [Full Text] [Related]  

  • 3. Degradation of deoxyribonucleic acid in Escherichia coli cells treated with mitomycin C.
    KERSTEN H; RAUEN HM
    Nature; 1961 Jun; 190():1195-6. PubMed ID: 13752694
    [No Abstract]   [Full Text] [Related]  

  • 4. Filament formation and resistane to 1-methyl-3-nitro-1-nitrosoguanidine and other radiomimetic compounds in Escherichia coli.
    KILGORE WW; GREENBERG J
    J Bacteriol; 1961 Feb; 81(2):258-66. PubMed ID: 13755934
    [No Abstract]   [Full Text] [Related]  

  • 5. RESISTANCE AND CROSS RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT NITROFURAZONE.
    WOODY-KARRER P; GREENBERG J
    J Bacteriol; 1963 Jun; 85(6):1208-16. PubMed ID: 14047210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protection of Escherichia coli against inhibition by 1-methyl-3-nitro-1-nitrosoguanidine.
    GREENBERG J; MORRIS J
    Antibiot Chemother (Northfield); 1961 Jan; 11():52-7. PubMed ID: 13708245
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance and cross-resistance of Escherichia coli mutants to anticancer agents. 1-Methyl-3-nitro-1-nitrosoguanidine.
    MANDELL JD; WOODY PL; GREENBERG J
    J Bacteriol; 1961 Mar; 81(3):419-24. PubMed ID: 13766075
    [No Abstract]   [Full Text] [Related]  

  • 8. RESISTANCE AND CROSS-RESISTANCE OF ESCHERICHIA COLI S MUTANTS TO THE RADIOMIMETIC AGENT PROFLAVINE.
    WOODY-KARRER P; GREENBERG J
    J Bacteriol; 1964 Mar; 87(3):536-42. PubMed ID: 14129667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of some antimicrobial preparations on the development of resistance to colimycin in colienteritis pathogens].
    KOVALENKO AD; CHERNOMORDIK AB
    Antibiotiki; 1961 Nov; 6():1021-5. PubMed ID: 14036903
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on induction of streptomycin resistance by streptomycin in Escherichia coli].
    LUECK H; RICKERL E
    Zentralbl Bakteriol; 1960 Mar; 178():25-42. PubMed ID: 13853721
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the drug resistance of enteric bacteria. 8. Comparison of the sulfonamide resistance in strains resistant to single and multiple sulfonamides obtained from nature].
    HARADA K; KAMEDA M; SUZUKI M; HASHIMOTO H; EGAWA R; MITSUHASHI S
    Nihon Saikingaku Zasshi; 1961 May; 16():371-4. PubMed ID: 13711411
    [No Abstract]   [Full Text] [Related]  

  • 12. MODE OF ACTION OF STREPTOMYCIN AND MECHANISM OF RESISTANCE TO THE DRUG IN BACTERIA.
    SUZUKI Y
    Jpn J Med Sci Biol; 1963 Aug; 16():235-9. PubMed ID: 14071909
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on some biological characteristics of Escherichia coli strains selected by sudden development of resistance to streptomycin].
    MOUTOUSES K; PAPABASILEIOU I; PAPADOPOULOU N
    Delt Hell Mikrobiol Hygieinol Hetair; 1960; 5():134-40. PubMed ID: 13773331
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of Escherichia coli against the growth-inhibiting effects of terephthalanilides by purines, pyrimidines, and amino acids.
    THAYER PS; GORDON HL
    Cancer Chemother Rep; 1962 Jun; 19():55-7. PubMed ID: 13920516
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of streptomycin resistance on the virulence of Shigella and coli-Shigella hybrids].
    STENZEL W
    Z Hyg Infektionskr; 1961; 148():152-6. PubMed ID: 13916845
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the cobalt-resistance in Escherichia coli. I. Studies on the permeability of cell wall of cobalt-resistant and sensitive Escherichia coli to cobalt ion.
    KATAYAMA Y
    Jpn J Microbiol; 1960 Oct; 4():351-6. PubMed ID: 14454228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of histidine and its metabolites on the biosynthesis of purines by Escherichia coli B. IV. Action on some cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 14400512
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of azaserine on Escherichia coli.
    KAPLAN L; REILLY HC; STOCK CC
    J Bacteriol; 1959 Oct; 78(4):511-9. PubMed ID: 14404400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of histidine and of its metabolites on the biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO-SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 13848416
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmissible drug-resistance factors and formation of multiple resistance.
    MITSUHASHI S; HARADA K
    Nature; 1962 Aug; 195():517-8. PubMed ID: 14474717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.